The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of September 2019. This month there are three guidelines that impact upon primary care.
The Attention deficit hyperactivity disorder guideline has been updated. It covers recognising, diagnosing and managing attention deficit hyperactivity disorder (ADHD) in children, young people and adults. It aims to improve recognition and diagnosis, as well as the quality of care and support for people with ADHD. The updated advises that an ECG is not necessary before starting stimulants, atomoxetine or guanfacine if cardiovascular history and examination are normal and the person is not on medicine that poses an increased cardiovascular risk.
The Pneumonia in adults guideline has been updated. It covers diagnosing and managing community- and hospital-acquired pneumonia in adults. The update withdrew some recommendations that have been replaced by antimicrobial prescribing guidance.
The Pneumonia (community-acquired): antimicrobial prescribing guideline has been published. It sets out an antimicrobial prescribing strategy for adults, young people, children and babies aged 72 hours and over with a confirmed diagnosis of community-acquired pneumonia. It aims to optimise antibiotic use and reduce antibiotic resistance.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.
|« Drug Safety Update - September 2019||CKS Updates - September 2019 »|